Literature DB >> 15884984

Benefits of cultural exposure and development of Korean perspective-taking ability for transracially adopted Korean children.

David C Lee1, Stephen M Quintana.   

Abstract

This study investigated the benefits of cultural exposure for transracially adopted (TRA) Korean children's developmental understanding of being Korean. Fifty TRA Korean children living in the United States were interviewed to assess their understanding of the implications of their Korean status for peer relations and personal identities, using a model of perspective-taking ability (PTA). Results showed cultural exposure and chronological age were significant predictors of children's PTA for being Korean. Cultural exposure had a slightly stronger relationship with PTA development for younger children than older ones. Comparison with another sample suggested that nonadopted native Korean children in the United States for an average of 25 months achieved levels of PTA at earlier ages did TRA children but that level of cultural exposure mediated these age differences. Copyright (c) 2005 APA, all rights reserved.

Entities:  

Mesh:

Year:  2005        PMID: 15884984     DOI: 10.1037/1099-9809.11.2.130

Source DB:  PubMed          Journal:  Cultur Divers Ethnic Minor Psychol        ISSN: 1077-341X


  3 in total

1.  Cultural socialization in families with internationally adopted children.

Authors:  Richard M Lee; Harold D Grotevant; Wendy L Hellerstedt; Megan R Gunnar
Journal:  J Fam Psychol       Date:  2006-12

2.  Comparing the Ethnic Identity and Well-Being of Adopted Korean Americans with Immigrant/U.S.-Born Korean Americans and Korean International Students.

Authors:  Richard M Lee; Andrea Bora Yun; Hyung Chol Yoo; Kim Park Nelson
Journal:  Adopt Q       Date:  2010-01

3.  Cultural identity and internationally adopted children: qualitative approach to parental representations.

Authors:  Aurélie Harf; Sara Skandrani; Jordan Sibeoni; Caroline Pontvert; Anne Revah-Levy; Marie Rose Moro
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.